Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
An open-label, single-arm, non-interventional, prospective, multicenter study involving primary data collection within real-world settings for patients who receive benralizumab for treatment of severe uncontrolled eosinophilic asthma
Epistemonikos ID: 1738402c21ccef8dd853fae82fdaef24559e8074
First added on: May 14, 2024